Safety and Efficacy of Patiromer in Hyperkalemic Patients with CKD: A Pooled Analysis of Three Randomized Trials.

Hermann Haller Stefano Bianchi Kieran MccaffertySusan ArthurCarol Moreno QuinnJeffery BuddenMatthew R Weir

Published in: Kidney360 (2022)

Patiromer was effective for treatment of hyperkalemia and well tolerated in patients across stages of CKD, most of whom were receiving guideline-recommended RAASi therapy.

Keyphrases

chronic kidney disease
end stage renal disease
ejection fraction
newly diagnosed
prognostic factors
randomized controlled trial
mesenchymal stem cells
replacement therapy
placebo controlled